Ramy Farid
CIK: 0001797707
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 27, 2026VIR
Vir Biotechnology, Inc.
Award(A)Direct8K shares- - Apr 17, 2026SDGR
Schrodinger, Inc.
Exercise(M)Direct74.5K shares at avg. $3.07$229K - Apr 17, 2026SDGR
Schrodinger, Inc.
Sale(S)Direct43K shares at avg. $12.21$525K - Apr 17, 2026SDGR
Schrodinger, Inc.
Exercise(M)Direct43K shares at avg. $3.07$132K - Apr 16, 2026SDGR
Schrodinger, Inc.
Exercise(M)Direct43K shares at avg. $3.07$132K - Apr 16, 2026SDGR
Schrodinger, Inc.
Sale(S)Direct43K shares at avg. $12.33$530K - Mar 5, 2026SDGR
Schrodinger, Inc.
Sale(S)Direct3.7K shares at avg. $12.91$47K - Mar 2, 2026SDGR
Schrodinger, Inc.
Sale(S)Direct5.6K shares at avg. $11.90$66K - Mar 2, 2026SDGR
Schrodinger, Inc.
Award(A)Direct48.3K shares- - Mar 2, 2026SDGR
Schrodinger, Inc.
Award(A)Direct13.6K shares- - Mar 2, 2026SDGR
Schrodinger, Inc.
Award(A)Direct56.3K shares- - May 30, 2025VIR
Vir Biotechnology, Inc.
Award(A)Direct8K shares- - Mar 3, 2025SDGR
Schrodinger, Inc.
Award(A)Direct37.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 |  VIR Vir Biotechnology, Inc. | Award(A) | 8,000 | - | $0 | Direct |
| Apr 17, 2026 |  SDGR Schrodinger, Inc. | Exercise(M) | 74,527 | $3.07 | $228,798 | Direct |
| Apr 17, 2026 | SDGR Schrodinger, Inc. | Sale(S) | 43,000 | $12.21 | $524,944 | Direct |
| Apr 17, 2026 | SDGR Schrodinger, Inc. | Exercise(M) | 43,000 | $3.07 | $132,010 | Direct |
| Apr 16, 2026 | SDGR Schrodinger, Inc. | Exercise(M) | 43,000 | $3.07 | $132,010 | Direct |
| Apr 16, 2026 | SDGR Schrodinger, Inc. | Sale(S) | 43,000 | $12.33 | $530,233 | Direct |
| Mar 5, 2026 | SDGR Schrodinger, Inc. | Sale(S) | 3,661 | $12.91 | $47,249 | Direct |
| Mar 2, 2026 | SDGR Schrodinger, Inc. | Sale(S) | 5,560 | $11.90 | $66,151 | Direct |
| Mar 2, 2026 | SDGR Schrodinger, Inc. | Award(A) | 48,259 | - | $0 | Direct |
| Mar 2, 2026 | SDGR Schrodinger, Inc. | Award(A) | 13,604 | - | $0 | Direct |
| Mar 2, 2026 | SDGR Schrodinger, Inc. | Award(A) | 56,250 | - | $0 | Direct |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | Award(A) | 8,000 | - | - | Direct |
| Mar 3, 2025 | SDGR Schrodinger, Inc. | Award(A) | 37,500 | - | - | Direct |
1-13 of 13 transactions
About Farid Ramy
Farid Ramy (SEC CIK 0001797707) files insider reports with the SEC as Director of Vir Biotechnology, Inc. (VIR) and President & CEO of Schrodinger, Inc. (SDGR).
Signal8 holds 6 ownership filings by Farid Ramy, all Form 4s, filed between Mar 4, 2025 and May 28, 2026. Those filings report 13 transactions, from Mar 3, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Farid Ramy's filings is in NEW YORK, NY.
Recent filings by Farid Ramy
- May 27, 2026: Grant or award of VIR shares (Form 4, code A).
- Apr 17, 2026: Option exercise of SDGR shares (Form 4, code M).
- Apr 17, 2026: Open-market sale of SDGR shares (Form 4, code S).
- Apr 17, 2026: Option exercise of SDGR shares (Form 4, code M).
- Apr 16, 2026: Option exercise of SDGR shares (Form 4, code M).
Other insiders filing for Vir Biotechnology, Inc. (VIR)
- Topalian Suzanne Louise, Director
- Sawaf Aziz, EVP, Chief Financial Officer
- MORE ROBERT J, Director
- Coughlin Timothy, Director
- Napolitano Janet, Director
- Sabatini Brent, SVP, Chief Accounting Officer